Commentaries
Imatinib: A New Tool for the Management of Chronic Sclerodermatous Graft-vs-Host Disease
Imatinib: Una nueva herramienta para el manejo de la enfermedad del injerto contra el hospedador crónica esclerodermiforme
C. Ferrándiz-Pulido
Servicio de Dermatología, Hospital Universitario Vall d’Hebron, Barcelona Sección: Comentario Editorial
Read
5878
Timeswas read the article
2194
Total PDF
3684
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 10 | 86 | 32 | 118 |
| 2025 9 | 76 | 19 | 95 |
| 2025 8 | 51 | 21 | 72 |
| 2025 7 | 73 | 26 | 99 |
| 2025 6 | 79 | 20 | 99 |
| 2025 5 | 113 | 31 | 144 |
| 2025 4 | 108 | 28 | 136 |
| 2025 3 | 146 | 14 | 160 |
| 2025 2 | 111 | 31 | 142 |
| 2025 1 | 65 | 23 | 88 |
| 2024 12 | 56 | 22 | 78 |
| 2024 11 | 100 | 44 | 144 |
| 2024 10 | 77 | 37 | 114 |
| 2024 9 | 65 | 20 | 85 |
| 2024 8 | 105 | 38 | 143 |
| 2024 7 | 71 | 33 | 104 |
| 2024 6 | 94 | 21 | 115 |
| 2024 5 | 62 | 26 | 88 |
| 2024 4 | 79 | 27 | 106 |
| 2024 3 | 75 | 26 | 101 |
| 2024 2 | 59 | 27 | 86 |
| 2024 1 | 57 | 28 | 85 |
| 2023 12 | 70 | 16 | 86 |
| 2023 11 | 71 | 25 | 96 |
| 2023 10 | 57 | 27 | 84 |
| 2023 9 | 67 | 26 | 93 |
| 2023 8 | 33 | 15 | 48 |
| 2023 7 | 42 | 32 | 74 |
| 2023 6 | 61 | 21 | 82 |
| 2023 5 | 40 | 20 | 60 |
| 2023 4 | 46 | 22 | 68 |
| 2023 3 | 56 | 39 | 95 |
| 2023 2 | 32 | 25 | 57 |
| 2023 1 | 41 | 41 | 82 |
| 2022 12 | 42 | 49 | 91 |
| 2022 11 | 14 | 31 | 45 |
| 2022 10 | 17 | 20 | 37 |
| 2022 9 | 21 | 37 | 58 |
| 2022 8 | 28 | 29 | 57 |
| 2022 7 | 24 | 30 | 54 |
| 2022 6 | 21 | 24 | 45 |
| 2022 5 | 36 | 34 | 70 |
| 2022 4 | 46 | 38 | 84 |
| 2022 3 | 44 | 58 | 102 |
| 2022 2 | 32 | 27 | 59 |
| 2022 1 | 33 | 53 | 86 |
| 2021 12 | 32 | 52 | 84 |
| 2021 11 | 45 | 56 | 101 |
| 2021 10 | 43 | 64 | 107 |
| 2021 9 | 27 | 40 | 67 |
| 2021 8 | 26 | 39 | 65 |
| 2021 7 | 30 | 31 | 61 |
| 2021 6 | 32 | 25 | 57 |
| 2021 5 | 36 | 57 | 93 |
| 2021 4 | 94 | 101 | 195 |
| 2021 3 | 73 | 49 | 122 |
| 2021 2 | 57 | 51 | 108 |
| 2021 1 | 45 | 48 | 93 |
| 2020 12 | 43 | 47 | 90 |
| 2020 11 | 26 | 30 | 56 |
| 2020 10 | 31 | 17 | 48 |
| 2020 9 | 31 | 25 | 56 |
| 2020 8 | 35 | 31 | 66 |
| 2020 7 | 32 | 22 | 54 |
| 2020 6 | 41 | 34 | 75 |
| 2020 5 | 10 | 13 | 23 |
| 2020 4 | 21 | 19 | 40 |
| 2020 3 | 30 | 9 | 39 |
| 2020 1 | 4 | 0 | 4 |
| 2019 12 | 10 | 0 | 10 |
| 2019 11 | 5 | 0 | 5 |
| 2019 9 | 10 | 0 | 10 |
| 2019 8 | 2 | 0 | 2 |
| 2019 7 | 6 | 0 | 6 |
| 2019 6 | 4 | 0 | 4 |
| 2019 5 | 6 | 0 | 6 |
| 2019 4 | 2 | 0 | 2 |
| 2019 3 | 2 | 0 | 2 |
| 2019 2 | 2 | 0 | 2 |
| 2018 12 | 2 | 0 | 2 |
| 2018 11 | 3 | 0 | 3 |
| 2018 10 | 1 | 0 | 1 |
| 2018 9 | 1 | 0 | 1 |
| 2018 4 | 2 | 0 | 2 |
| 2018 3 | 0 | 1 | 1 |
Show all
